Licorice-derived prenylated chalcones alleviate knee osteoarthritis via multi-target modulation of PI3K-Akt, MAPK and HIF-1α signaling: an integrative UPLC-Q-TOF-MS/MS, network pharmacology and molecular dynamics study
Knee osteoarthritis (KOA) remains a leading cause of global disability, yet no disease-modifying osteoarthritis drug (DMOAD) has been approved. This exploratory computational study aimed to elucidate the potential bioactive basis and mechanism of action of a clinically used licorice extract against KOA. UPLC-Q-TOF-MS/MS profiling identified 1,071 metabolites, among which prenylated chalcones—including glabrene, 4′-O-methylglabridin, butein and echinatin—were selected as candidate chemotypes for further investigation based on their known pharmacological activities and relative abundance. Network pharmacology revealed 309 overlapping targets between these constituents and KOA-related genes; topological analysis identified TNF, AKT1, GAPDH and HIF1A as highly connected nodes. Functional enrichment indicated that PI3K-Akt, MAPK and HIF-1α pathways are among the principal predicted intervention axes. Molecular docking showed favorable predicted binding energies (≤−8.4 kcal mol -1 ) of the key chalcones for the hub proteins, and 100-ns GROMACS simulations confirmed structurally stable binding sustained by persistent hydrogen bonds and low residue flexibility (RMSF <4 Å). Collectively, these computational findings suggest that licorice prenylated chalcones may exert multi-target, multi-pathway effects potentially relevant to suppressing inflammation, apoptosis and extracellular-matrix degradation in joint tissues. These findings provide a hypothesis-generating framework for developing prenyl-chalcone-based DMOADs and demonstrate the utility of integrating untargeted metabolomics with network pharmacology for botanical drug discovery hypothesis generation.